Another controversial FDA approval for a new Alzheimer’s medication

The US Food and Drug Administration (FDA) has approved a new drug for patients in the early stages of Alzheimer’s disease. The treatment, called Leqembi (lecanemab), was heralded as a major breakthrough in the treatment of Alzheimer’s disease last year…







